dinitrofluorobenzene has been researched along with Granuloma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hudemann, B; Nizze, H; Riedel, H; Seyfarth, M; Werner, H | 1 |
Bergstrand, H; Jansson, AH; Matuseviciene, G; Pierrou, S; Särnstrand, B; Scheynius, A | 1 |
2 other study(ies) available for dinitrofluorobenzene and Granuloma
Article | Year |
---|---|
Local BCG-immunotherapy in bladder cancer patients. Immunological follow-up studies.
Topics: Aged; Antigens, Neoplasm; BCG Vaccine; Dinitrofluorobenzene; Female; Granuloma; Humans; Lymphocytes; Male; Middle Aged; Skin Tests; Transaminases; Urinary Bladder Neoplasms | 1982 |
N,N'-Diacetyl-L-cystine-the disulfide dimer of N-acetylcysteine-is a potent modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents.
Topics: Acetylcysteine; Adjuvants, Immunologic; Animals; CD8-Positive T-Lymphocytes; Cystine; Dermatitis, Contact; Dinitrofluorobenzene; Ear; Female; Fluorescein-5-isothiocyanate; Foot; Granuloma; Hypersensitivity, Delayed; Immunohistochemistry; Lymphocyte Count; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Oxazolone; Rabbits; Serum Albumin, Bovine | 1999 |